Monte Rosa Therapeutics Inc (GLUE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	113.02% 8.968	4.21	2.781	12.77	23.19
Operating Expenses	7.10% 58.10	54.24	52.50	45.74	38.75
Operating Income/Loss	1.81% -49.13	-50.03	-49.72	-32.98	-15.55
Nonoperating Income/Loss	6.41% 5.941	5.583	3.639	2.717	4.458
Income/Loss From Continuing Operations Before Tax	2.84% -43.19	-44.45	-46.08	-30.26	-11.10
Income Tax Expense/Benefit	300.00% 0.208	0.052	0.059	-3.177	1.199
Net Income/Loss	2.49% -43.40	-44.50	-46.13	-27.08	-12.29
Basic Average Shares	1.60% 101.48	99.88	-	82.40	82.19
Diluted Average Shares	1.60% 101.48	99.88	-	82.40	82.19

CGEM

$12.93

7.64%

ABUS

$4.22

1.63%

ODTX

$17.17

2.28%

AKTS

$15.06

5.93%

AVBP

$16.66

0.77%

MLTX

$9.55

6.92%